NEW YORK, March 02, 2017 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against FXCM Inc. (“FXCM” or the “Company”) (NASDAQ:FXCM) and certain of its officers, on behalf of a class who purchased FXCM securities between March 15, 2012 and February 6, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/fxcm.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) between September 4, 2009 through at least 2014, FXCM’s U.S. subsidiary were engaged in false and misleading solicitations of its retail foreign exchange customers by hiding its relationship with its most important market maker and by misrepresenting that its “No Dealing Desk” platform had no conflicts of interest with its customers; (2) FXCM’s U.S. subsidiary made false statements to the National Futures Association about its relationship with the market maker; and (3) consequently, Defendants’ statements regarding FXCM’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
On February 6, 2017, the Commodities Futures Trading Commission (“CFTC”) found that FXCM was engaged in false and misleading solicitations of its retail foreign exchange customers by hiding its relationship with FXCM’s most important market maker and the fact that the Company’s “No Dealing Desk” platform had conflicts of interest with FXCM’s customers. Due to the above, CFTC barred FXCM from operating in the United States. Following this news, FXCM stock dropped $3.40 per share, or 50%, to close at $3.45 on February 7, 2017.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/fxcm or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in FXCM you have until April 10, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



